NCT00316654View on ClinicalTrials.gov

Persistence of Antibody Response to N. Meningitidis Group C in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

489

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Prevention of Meningococcal Infection
Interventions
BIOLOGICAL

Meningococcal C conjugate vaccine

Trial Locations (2)

Unknown

Olsztyn, Lubartów, Kielce, Kraków, Bydgoszcz

Valencia

Sponsors

Lead Sponsor

Novartis Vaccines

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Novartis Vaccines

INDUSTRY